Janus Henderson Group PLC Inovio Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.79 - $1.91 $47,394 - $114,586
59,993 Added 142.43%
102,114 $83,000
Q4 2022

Feb 14, 2023
BUY
$1.41 - $2.5 $1 - $2
1 Added 0.0%
42,121 $65,000
Q3 2022

Nov 14, 2022
BUY
$1.66 - $2.79 $200 - $337
121 Added 0.29%
42,120 $72,000
Q2 2022

Aug 15, 2022
BUY
$1.44 - $3.98 $7 - $19
5 Added 0.01%
41,999 $73,000
Q1 2022

May 16, 2022
BUY
$2.97 - $5.2 $124,722 - $218,368
41,994 New
41,994 $151,000

Others Institutions Holding INO

# of Institutions
10
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About INOVIO PHARMACEUTICALS, INC.

INO Quotes by TradingView
  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $459M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email